Fine needle aspiration cytology of lobular carcinoma in situ on ThinPrep®

Diagnostic Cytopathology

Volumn 32, Issue 5, 2005, Pages 276-280

  Ayata, Gamze ^a,b   Wang, Helen H ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Breast; Cytology; Fine needle aspiration; Lobular carcinoma in situ

Indexed keywords

ASPIRATION BIOPSY; BIOPSY TECHNIQUE; CANCER INVASION; CARCINOMA IN SITU; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EXCISION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; NEEDLE BIOPSY; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CELL NUCLEUS; CYTODIAGNOSIS; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED;

EID: 17844387085     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20247     Document Type: Review

References (23)

1. Sneige N. Fine-needle aspiration cytology of in situ epithelial cell proliferation in the breast. Am J Clin Pathol 2000;113(Suppl 1):S38-S48.
2. Wang HH, Ducatman BS. Fine needle aspiration of the breast. A probabilistic approach to diagnosis of carcinoma. Acta Cytol 1998; 42:285-289.
3. Wang HH, Ducatman BS, Eick D. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy. Am J Clin Pathol 1989;92:736-740.
4. McKee GT, Tildsley G, Hammond S. Cytologic diagnosis and grading of ductal carcinoma in situ. Cancer 1999;87:203-209.
5. McKee GT, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma. Diagn Cytopathol 2001;25:73-77.
6. Salhany KE, Page DL. Fine-needle aspiration of mammary lobular carcinoma in situ and atypical lobular hyperplasia. Am J Clin Pathol 1989;92:22-26.
7. Üstün M, Berner A, Davidson B, Risberg B. Fine-needle aspiration cytology of lobular carcinoma in situ. Diagn Cytopathol 2002; 27:22-26.
8. Tabbara SO, Frost AR, Stoler MH, Sneige N, Sidawy MK. Changing trends in breast fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Survey. Diagn Cytopathol 2000; 22:126-130.
9. Andersen JA. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer 1977;39:2597-2602.
10. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42:737-769.
11. Gump FE. Kinne D, Schwartz GF. Current treatment for lobular carcinoma in situ. Ann Surg Oncol 1998;5:33-36.
12. Henry-Tillman RS, Klimberg VS. In situ breast cancer. Curr Treat Options Oncol 2000;1:199-209.
13. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 2004;100:238-244.
14. Masood S, Lu L, Assaf-Munasifi M, McCaulley K. Application of immunostaining for muscle specific actin in detection of myoepithelial cells in breast fine-needle aspirates. Diagn Cytopathol 1995; 13:71-74.
15. Reis-Filho JS, Albergaria A, Milanezi F, Amendoeira I. Schmitt FC. Naked nuclei revisited: p63 Immunoexpression. Diagn Cytopathol 2002;27:135-138.
16. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 1999;16:209-223.
17. Liberman L, Sama M, Susnik B, Rosen PP, LaTrenta LR, Morris EA, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 1999;173: 291-299.
18. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000;216:831-837.
19. Greeley CF, Frost AR. Cytologic features of ductal and lobular carcinoma in fine needle aspirates of the breast. Acta Cytol 1997; 41:333-340.
20. Rajesh L, Dey P, Joshi K. Fine needle aspiration cytology of lobular breast carcinoma. Comparison with other breast lesions. Acta Cytol 2003;47:177-182.
21. Mosunjac MB, Lewis MM, Lawson D, Cohen C. Use of a novel marker, calponin, for myoepithelial cells in fine-needle aspirates of papillary breast lesions. Diagn Cytopathol 2000;23:151-155.
22. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001;25:229-236.
23. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002;33: 620-627.